NCT03353818 is a NA clinical trial of Golf in Type2 Diabetes, sponsored by Alexander Christensen.

Who is sponsoring NCT03353818?

NCT03353818 is sponsored by Alexander Christensen.

What drugs are being tested in NCT03353818?

Interventions in NCT03353818: Golf, No intervention.

What condition does NCT03353818 study?

NCT03353818 studies Type2 Diabetes.

Is NCT03353818 still recruiting?

NCT03353818 is currently status unknown. Last updated 27 November 2017.

Last reviewed 2017-11-27 · How we verify

NCT03353818

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Golf and Diabetes.

Status unknown NA Last updated 27 November 2017

What this trial tests

NA trial testing Golf in Type2 Diabetes in 45 participants. Status unknown.

Timeline

1 May 2017

Primary endpoint
1 May 2018

1 July 2018

Quick facts

Lead sponsor	Alexander Christensen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	1 May 2017
Primary completion	1 May 2018
Estimated completion	1 July 2018
Sites	2 locations across Denmark

Drugs / interventions tested

Golf
No intervention

Conditions studied

Type2 Diabetes — all drugs for Type2 Diabetes →

Sponsor

Alexander Christensen

Who can join

18 and older, any sex, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This a randomised, single-blinded, controlled study that investigate if a free golf training programme will increase the physical activity of type 2 diabetes patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Golf

Trials testing the same drug.

NCT03462485 — Pilot Study of the Effects of Playing Golf on People With Dementia · NA · unknown

Other recruiting trials for Type2 Diabetes

Currently open trials in the same condition.

NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting
NCT05015283 — Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission · NA · recruiting
NCT05006508 — Prevention With the Health and Lifestyle Tool · NA · active not recruiting
NCT04717050 — Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity · NA · active not recruiting
NCT05220917 — Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03353818 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexander Christensen
Last refreshed: 27 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing